U3 Pharma GmbH
Records under this name other than patents U3 Pharma GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,100,124 | Antibodies Directed to HER-3 and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,988,462 | Material and Methods for Treating or Preventing HER-3 Associated Diseases Formerly held In force · High confidence | In force | High confidence | |
| US 7,705,130 | Antibodies Directed to HER-3 and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,249,230 | Antibodies Directed to HER-3 and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,803,025 | Material and Methods for Treating or Preventing HER-3 Associated Diseases Formerly held In force · High confidence | In force | High confidence | |
| US 10,365,283 | Activated HER3 as a marker for predicting therapeutic efficacy Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,771,695 | Antibodies directed to HER-3 and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,828,382 | Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding Proteins Formerly held In force · High confidence | In force | High confidence | |
| US 9,101,760 | Material and Methods for Treating or Preventing HER-3 Associated Diseases Formerly held In force · High confidence | In force | High confidence | |
| US 10,357,566 | HER3 inhibitor for modulating radiosensitivity Formerly held In force · USPTO record | In force | USPTO record |